Literature DB >> 1499439

Cytokine effects in a human colonic goblet cell line. Cellular damage and its partial prevention by 5 aminosalicylic acid.

A Jarry1, F Muzeau, C Laboisse.   

Abstract

The aim of the present study was to investigate the effects of cytokines on intestinal goblet cells in vitro. For this purpose, we examined the effects of recombinant interferon gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) on the human colonic goblet cell line Cl.16E by morphological and kinetic studies, and by the assessment of mucus production during IFN-gamma/TNF-alpha treatment. Control cultures of Cl.16E cells grown on nitrocellulose filters formed monolayers of polarized goblet cells, which had kinetic characteristics similar to those of a differentiated epithelium in steady state. The combined action of IFN-gamma and TNF-alpha caused a dose-related cellular exfoliation, leading to the formation of a mucoid cap made of mucus and cellular debris. The remaining viable cells underlying the mucoid cap were cuboidal and devoid of mucus granules. A dose-related increase in cellular incorporation of [3H]thymidine was reactive to the cytokine-induced cell loss. The synergistic effects of IFN-gamm and TNF-alpha were found to be reversible when the cells were reincubated in a culture medium without cytokines. Furthermore, 5-aminosalicylic acid partially protected Cl.16E cells against cellular injury caused by IFN-gamma and TNF-alpha. On the whole, these morphological and kinetic findings argue that the changes induced in Cl.16E cells by IFN-gamma and TNF-alpha closely parallel those observed during the acute phase of ulcerative colitis, and show that these cytokines can regulate intestinal mucus production by modulating cellular exfoliation, thus leading probably to a reinforced protection of the damaged mucosa.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1499439     DOI: 10.1007/bf01296556

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

Review 1.  Immune events associated with inflammatory bowel disease.

Authors:  C Fiocchi
Journal:  Scand J Gastroenterol Suppl       Date:  1990

2.  Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine.

Authors:  T T MacDonald; P Hutchings; M Y Choy; S Murch; A Cooke
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

3.  Classification of intractable diarrhea in infancy using clinical and immunohistological criteria.

Authors:  B Cuenod; N Brousse; O Goulet; S De Potter; J F Mougenot; C Ricour; D Guy-Grand; N Cerf-Bensussan
Journal:  Gastroenterology       Date:  1990-10       Impact factor: 22.682

4.  Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma.

Authors:  V Ruggiero; J Tavernier; W Fiers; C Baglioni
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

5.  Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion.

Authors:  L Staerk Laursen; M Stokholm; K Bukhave; J Rask-Madsen; K Lauritsen
Journal:  Gut       Date:  1990-11       Impact factor: 23.059

6.  Effect of tumor necrosis factor on epithelial tight junctions and transepithelial permeability.

Authors:  J M Mullin; K V Snock
Journal:  Cancer Res       Date:  1990-04-01       Impact factor: 12.701

7.  Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis.

Authors:  M S Caplan; X M Sun; W Hseuh; J R Hageman
Journal:  J Pediatr       Date:  1990-06       Impact factor: 4.406

8.  The synergistic cytocidal effect produced by immune interferon and tumor necrosis factor in HT-29 cells is associated with inhibition of rRNA processing and (2',5') oligo (A) activation of RNase L.

Authors:  M S Chapekar; R I Glazer
Journal:  Biochem Biophys Res Commun       Date:  1988-03-30       Impact factor: 3.575

9.  Mechanisms of mucus release in exposed canine gastric mucosa.

Authors:  C A Zalewsky; F G Moody
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

10.  Cytotoxicity of tumor necrosis factor for thyroid epithelial cells and its regulation by interferon-gamma.

Authors:  J Taverne; D C Rayner; P H Van der Meide; P M Lydyard; S P Bidey; A Cooke
Journal:  Eur J Immunol       Date:  1987-12       Impact factor: 5.532

View more
  8 in total

1.  Adhesion of human enterotoxigenic Escherichia coli to human mucus secreting HT-29 cell subpopulations in culture.

Authors:  S Kerneis; M F Bernet; M H Coconnier; A L Servin
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

2.  Goblet cell mucins as the selective barrier for the intestinal helminths: T-cell-independent alteration of goblet cell mucins by immunologically 'damaged' Nippostrongylus brasiliensis worms and its significance on the challenge infection with homologous and heterologous parasites.

Authors:  N Ishikawa; Y Horii; T Oinuma; T Suganuma; Y Nawa
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

3.  Effect of roxithromycin on mucosal damage, oxidative stress and pro-inflammatory markers in experimental model of colitis.

Authors:  Hilal Ahmad; Sneh Verma; Vijay L Kumar
Journal:  Inflamm Res       Date:  2017-10-07       Impact factor: 4.575

4.  Listeria monocytogenes stimulates mucus exocytosis in cultured human polarized mucosecreting intestinal cells through action of listeriolysin O.

Authors:  M H Coconnier; E Dlissi; M Robard; C L Laboisse; J L Gaillard; A L Servin
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

5.  Mucosal IL-10 and TGF-beta play crucial roles in preventing LPS-driven, IFN-gamma-mediated epithelial damage in human colon explants.

Authors:  Anne Jarry; Céline Bossard; Chantal Bou-Hanna; Damien Masson; Eric Espaze; Marc G Denis; Christian L Laboisse
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

6.  Modulation of conjunctival goblet cell function by inflammatory cytokines.

Authors:  L Contreras-Ruiz; A Ghosh-Mitra; M A Shatos; D A Dartt; S Masli
Journal:  Mediators Inflamm       Date:  2013-12-17       Impact factor: 4.711

Review 7.  Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview.

Authors:  N M Blijlevens; J P Donnelly; B E De Pauw
Journal:  Bone Marrow Transplant       Date:  2000-06       Impact factor: 5.483

8.  Interleukin 4 induces rapid mucin transport, increases mucus thickness and quality and decreases colitis and Citrobacter rodentium in contact with epithelial cells.

Authors:  S Sharba; N Navabi; M Padra; J A Persson; M P Quintana-Hayashi; J K Gustafsson; L Szeponik; V Venkatakrishnan; Å Sjöling; S Nilsson; M Quiding-Järbrink; M E V Johansson; S K Linden
Journal:  Virulence       Date:  2019-12       Impact factor: 5.882

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.